Here are relevant reports on : drug-delivery-market
-
Europe Pharmaceutical Drug Delivery Market by Route of Administration [Oral (Tablet, Capsule), Injector, Topical (Cream, Transdermal Patch), Transmucosal, Nasal], Application [Cancer, Diabetes], Care Setting [Hospital, Homecare]- Forecast to 2031
The Europe Pharmaceutical drug delivery market, valued at USD501.62 billion in 2025, stood at USD519.62 billion in 2026 and is projected to advance at a resilient CAGR of 6.2% from 2026 to 2031, culminating in a forecasted valuation of USD703.19 billion by the end of the period. The market growth is driven by rising use of biologics and biosimilars, an increasing prevalence of chronic diseases, and growing acceptance of innovative drug delivery devices, including auto-injectors, prefilled syringes, and inhalation systems.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
US Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer, Obesity), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), End Users (Hospital, Home Care) - Forecast to 2031
The US injectable drug delivery market, valued at US$285.81 billion in 2025, stood at US$309.90 billion in 2026 and is projected to advance at a resilient CAGR of 8.5% from 2026 to 2031, culminating in a forecasted valuation of US$465.15 billion by the end of the period. The growth of the veterinary contract manufacturing & research market is driven by the increasing adoption of biologics and long-acting injectables, rising demand for patient-centric and self-administration delivery systems, and the need for advanced formulation, device engineering, and scalable manufacturing capabilities.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Pulmonary/ Respiratory Drug Delivery Market by Formulation (Type (Solution, Suspension, Dry powder), Device Type (Metered dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End User (Hospitals, Homecare), Applications (COPD) - Global Forecast to 2021
The global pulmonary drug delivery market is projected to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in 2016, at a CAGR of 6.5% during the forecast period. Growth in this market is mainly driven by increasing preference of pulmonary route as an alternate route of drug delivery, rising focus on the development of smart/digital inhalers and increasing incidence of respiratory diseases such as COPD, asthma, and cystic fibrosis. Emerging markets such as India, China, & Japan and growth in online marketing channels are expected to offer lucrative growth opportunities for market players in the coming years. On the other hand, factors such as regulatory issues and pricing pressures are the major factors restraining market growth.
- Published: February 2017
- Price: $ 4950
- TOC Available:
-
Latin America Pharmaceutical Drug Delivery Market by Route of Administration [Injectable (Prefilled Syringe, Self Injection Devices), Oral (Tablet, Capsule, Liquid), Topical, Buccal, Nasal, Rectal], Application (Cancer, Diabetes, CVD) - Forecast to 2031
The latin america pharmaceutical drug delivery market, valued at USD 72.7BN in 2025, stood at USD 75.3BN in 2026 and is projected to advance at a resilient CAGR of 6.3% from 2026 to 2031, culminating in a forecasted valuation of USD 102.1BN by the end of the period. Some of the prominent players in the Latin America pharmaceutical drug delivery market include Pfizer Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Novartis AG (Switzerland), Sanofi (France), AstraZeneca (UK), GSK Plc (UK), Eurofarma (Brazil), Bayer AG (Germany), EMS (Brazil), BD (US), Teva Pharmaceutical Industries Ltd. (Israel), and Hypera Pharma (Brazil).
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Europe Injectable Drug Delivery Market by Product (Device, Self Injection, Formulation, Solution, Emulsions), Formulation Packaging (Ampoules, Bottles), Therapeutic Application (Obesity, Diabetes, Cancer, Psoriasis), Usage Pattern - Forecast to 2031
The Europe injectable drug delivery market, valued at US$166.13 billion in 2025, stood at US$178.87 billion in 2026 and is projected to advance at a resilient CAGR of 7.7% from 2026 to 2031, culminating in a forecasted valuation of US$259.49 billion by the end of the period. The increasing use of biologics, biosimilars, and long-acting injectables is driving market growth. There is an increasing demand for patient-centric delivery systems and self-administration in major healthcare markets.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Injectable Drug Delivery Market by Product (Device, Autoinjectors, Formulation, Suspensions, Nanoparticles), Site of Administration (Dermal, Organ), Formulation Packaging (Ampoules, Vials), Usage Pattern (Curative, Immunization) - Forecast to 2031
The Asia Pacific injectable drug delivery market, valued at US$161.32 billion in 2025, stood at US$176.96 billion in 2026 and is projected to advance at a resilient CAGR of 9.8% from 2026 to 2031, culminating in a forecasted valuation of US$282.22 billion by the end of the period. The growth of the Asia Pacific injectable drug delivery market is driven by the increasing incorporation of biologics, biosimilars, and long-acting injectables, alongside a rapidly growing patient population and an escalating burden of chronic diseases across major countries in the region.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Adhesive for Drug Delivery System Market by Resin Type, Technology and Geography - Global Forecast to 2019
This study estimates the global adhesive for drug delivery system for 2013 and projects the expected demand of the same by 2019. This market research study provides a detailed qualitative and quantitative analysis of the global adhesive for drug delivery system. It also includes a comprehensive review of major market drivers, restraints, opportunities, winning imperatives, challenges, and key issues in the market. The market is further segmented and forecast based by major regions North America, Europe, Asia-Pacific and RoW (Rest of the World). Market size for major countries of each region in terms of volume and value are covered.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Top 10 Drug Delivery Technologies Market (Topical, Oral Time Release/Sustained Release, Targeted Delivery, Encapsulation, Aerosol/Inhalation, Transdermal, Implants, Injectable, Liposomal, Pegylation) - Global Trends, Challenges & Forecasts up till 2015
This report provides industry analysis, competitive landscape and in-depth market segmentation for all the top 10 drug delivery technologies. It provides market data for the oral delivery system, which still dominates the drug delivery market. In addition, the report also analyzes the market data on emerging drug delivery technologies like needleless injectables, PEGylation technologies and microelectromechanical devices.
- Published: February 2011
- Price: $ 4950
- TOC Available:
-
European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017
The Europeandrug delivery market was worth $39.9 billion in the year 2012. The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery.
- Published: June 2013
- Price: $ 4950
- TOC Available:
-
Multi-Lumen Medical Tubing Market by Material (Plastic, Rubber, Specialty Polymers), Application (Bulk Disposable Tubing, Catheters & Cannulas, Drug Delivery Systems), and Country - Global Forecast to 2030
The multi-lumen medical tubing market is projected to grow from USD 8.02 billion in 2026 to USD 10.83 billion by 2030, at a CAGR of 7.8% during the forecast period. The Key Players Arkema (France), Avient Corporation (US), BASF (Germany), Celanese Corporation (US), Covestro (Germany), DuPont (US), Evonik (Germany), Lubrizol Corporation (US), Saint-Gobain Performance Plastics (France), and Solvay (Belgium).
- Published: May 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
